Viewing Study NCT00306293


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2026-03-21 @ 7:31 AM
Study NCT ID: NCT00306293
Status: COMPLETED
Last Update Posted: 2018-03-23
First Post: 2006-03-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Herpes Labialis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent Genital Herpes View